Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mother's lullaby or kangaroo care: a gentle sleep aid for tiny patients?

NCT ID NCT07725094

Not yet recruiting Symptom relief Sponsor: Kirsehir Ahi Evran Universitesi Source: ClinicalTrials.gov ↗

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether gentle sensory interventions from mothers — kangaroo care (skin-to-skin contact), lullabies, or soothing touch and voice — can help newborns in the neonatal intensive care unit fall asleep faster and sleep more deeply. Researchers will monitor sleep states, heart rate, and breathing in 80 stable newborns. The goal is to see if these simple, drug-free approaches can improve rest and stability for hospitalized infants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
maternal sensory stimulation (kangaroo care, lullabies, tactile-auditory soothing)
What this could lead to
If effective, these simple, drug-free interventions could improve sleep quality and stability for newborns in intensive care, supporting their development.
What could go wrong
This is a small, early-stage trial. Results may not apply to all newborns, and the effects on long-term outcomes are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HOSPITALIZED NEWBORN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HOSPITALIZED NEWBORN NEONATAL INTENSIVE CARE UNIT

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kirsehir Ahi Evran Universty

    Kırşehir, Kırşehir, 40100, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.